Thrombectomy Devices Market Size & Share, by End user (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics); Product Type; Application; Technology; Utility; Clot Type - Global Supply & Demand Analysis, Growth Forecasts, Statistical Report 2026-2035

Thrombectomy Devices Market - Regional Analysis

North America Market Insights

North America is anticipated to be the dominating region by account for the largest market share of 40.5% by the end of 2035. The market’s growth in the region is propelled by harmonized regulatory policies, integrated supply chains, cross-border clinical studies, and the presence of notable players. For instance, in June 2025, Inquis Medical’s AVENTUS Thrombectomy System has successfully achieved the U.S. Food and Drug Administration (FDA) 510(k) clearance. The purpose of this was to extend the indications for effectively aiding pulmonary embolism, thereby suitable for the market’s upliftment.

U.S. is growing significantly, owing to the presence of the CMS Inpatient Prospective Payment System (IPPS), consolidated hospitals, increased prevalence of comorbidities, as well as a high litigation environment. According to a report published by AHA Journals in November 2023, almost half of the population in the country is projected to be obese, which includes 1 in 4 people being severely affected with this condition by the end of 2030. Besides, 78% of hypertension among men and 65% among women is readily attributable to obesity, thus enhancing the market’s demand in the country.

The thrombectomy devices market in Canada is also growing due to the existence of provincial health technology assessment (HTA), single-payer system availability, the presence of concentrated urban centers, and provincial bulk purchasing. As stated in the Obesity Canada November 2024 report, the inaction expense of successfully aiding obesity in the country has reached USD 27.6 billion, which accounts for almost 20% than the previous estimation. In addition, with nearly 1 in 3 people residing with this condition, both direct and indirect expenses are staggering.

Obesity Incidence in North America

Sources: Obesity Medicine Organization, June 2024; Government of Canada, June 2025

APAC Market Insights

Asia Pacific market is projected to be the fastest-growing region during the forecast period. The market’s growth in the region is subject to disproportionate disease burden of stroke cases, extreme economic diversity, rapid development of facilities for aiding stroke, and diversified regulatory pathways. As per the April 2024 NLM article, an estimated 9.5 to 10.6 million stroke cases will affect the region every year. Besides, the mortality rate in Singapore is moderate, accounting for 47.9% per 100,000 person-years, and highest in Indonesia, with 193.3% per 100,000 person-years, thus suitable for the market’s growth.

The thrombectomy devices market in China is gaining increased traction, owing to the existence of the centralized Healthy China 2030 plan, the presence of sheer patient volume, the NMPA’s fast-track clearance for regional innovation, and the availability of the tiered hospital system. According to an article published by NLM in April 2022, over 2 million patients in the country have utilized outpatient services, particularly at the Peking University First Hospital in each year. Based on this, it has been noted that the average growth rate for outpatients has been 16.6%, with the utilization rate being 54.1%, thereby denoting the market’s requirement in the country.

India market is also growing due to extreme price sensitivity, an effective shortage of trained specialists, fragmentation in public health funding, and an increase in the young stroke population. As stated in the February 2022 NLM article, the overall neurological diseases caused by stroke have been determined to be 37.9%, with a 95% uncertainty level. In addition, between 20 to 64 years of age, there has been a surge in stroke deaths by almost 36.7%. Therefore, with all these incidents, there is a huge opportunity for the market to flourish in the country.

Europe Market Insights

Europe market is expected to account for a considerable share by the end of the projected timeline. The market’s upliftment in the region is highly fueled by centralized regional MDR acceptance, the presence of the EU4Health programme support, domestic clinical guidelines availability, and price preference between markets. As per the March 2023 NLM article, health technology is an essential industry for the Finnish economy, and its exports over the past 5 years totaled to almost EUR 2.5 billion. In addition, the overall healthcare in the country has been effectively digitalized in both private and public sectors, which is positively contributing towards the market’s growth in the overall region.

Germany market is steadily growing, owing to the existence of the innovative G-BA process, compulsory stroke unit certification, diagnosis-based group system, and a rapid increase in the aging population. According to the 2023 OECD report, circulatory disorders in the country accounted for more than 33% of deaths in 2021. In addition, cancer constitutes 22% of overall deaths, with lung cancer being the most common cause of death in the country, thus denoting a positive outlook for enhancing the market’s dominance in the overall country, which in turn has increased export and import of catheters as well.

The thrombectomy devices market in France is also developing due to the presence of a top-down national stroke strategy, mission-based hospital funding, centralized facility, and stringent cost-effective demands. As stated in the May 2025 NLM article, there has been an increase in specialists, especially in the country’s private sector, by 57.4% as of 2022, in comparison to 38.0% in previous years. Besides, the majority of funding in the domestic healthcare is contributed by employee and employer payroll, accounting for 33%, 24% of general social contributions, and 20% of other taxes.

Needles, Catheters, and Cannula 2023 Export and Import in Europe

Source: OEC, July 2025